Oncopeptides AB (publ)

ONPPF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$178,536$173,407$344,515$362,187
Short-Term Investments$0$32$0$0
Receivables$11,139$2,194$674$11,873
Inventory$4,371$2,425$0$0
Other Curr. Assets$23,035$24,842$18,497$36,201
Total Curr. Assets$217,081$202,900$364,034$412,373
Property Plant & Equip (Net)$27,111$34,626$20,438$24,744
Goodwill$0$0$0$0
Intangibles$0$0$0$1,408
Long-Term Investments$0$0$851$851
Tax Assets$0$0$0-$851
Other NC Assets$0$852$0-$26,152
Total NC Assets$27,111$35,478$21,289$27,003
Other Assets$0$0$0$0
Total Assets$244,192$238,378$385,323$439,376
Liabilities
Payables$18,171$15,025$28,219$35,702
Short-Term Debt$0$0$5,999$10,987
Tax Payable$0$579$6,778$7,025
Deferred Revenue$0$0$28,060$128,681
Other Curr. Liab.$33,184$29,329$16,616$42,894
Total Curr. Liab.$51,355$44,933$85,672$225,289
LT Debt$134,442$126,156$3,543$3,206
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$4,110$10,509$1,815$13
Total NC Liab.$138,552$136,665$5,358$3,219
Other Liabilities$0$0$0$0
Cap. Leases$12,548$19,669$9,542$14,193
Total Liabilities$189,907$181,598$91,030$228,508
Equity
Pref Stock$0$0$0$0
Common Stock$0$10,511$10,479$8,366
Retained Earnings$0-$5,365,987-$5,116,414-$4,778,463
AOCI$0-$2,199-$2,297-$918
Other Equity$54,285$5,414,455$5,402,525$4,981,883
Total Equity$54,285$56,780$294,293$210,868
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$244,192$238,378$385,323$439,376
Net Debt-$44,094-$47,251-$334,973-$347,994